RESUMO
Objective@#To investigate the willingness to receive a COVID-19 vaccination and its influencing factors among individuals that missed the second dose of the inactivated COVID-19 vaccine in Zhejiang Province, so as to provide the evidence for improving the strategy for COVID-19 vaccination.@*Methods@#Individuals that did not receive the second dose of the inactivated COVID-19 vaccine after 56 days of getting the first dose (missed individuals) from March and May, 2021, were randomly sampled from Zhejiang Provincial SaaS Vaccination Information System. Their basic information, status of getting the inactivated COVID-19 vaccine and willingness to receive the second dose of the inactivated COVID-19 vaccine were collected through telephone interviews. The factors affecting the willingness to receive the second dose of the inactivated COVID-19 vaccine were identified among the missed individuals using a multivariable logistic regression model. @* Results@# Totally 562 individuals were investigated, and there were 292 (51.96%) valid respondents. There were 54 actual missed individuals, with a mean age of (40.91±16.75) years, which included 39 men (72.22%) and 15 women (27.78%). Of all missed individuals, 23 had an educational level of junior high school and below (42.59%). The mean duration from the time of investigation to the time of getting the first dose of the inactivated COVID-19 vaccine was (137±28) days. A half of the missed individuals were willing to receive the second dose of the inactivated COVID-19 vaccine. Multivariable logistic regression analysis showed high willingness to receive the second dose of the inactivated COVID-19 vaccine among the missed individuals with requirements of vaccination in the workplace (OR=5.393, 95%CI: 1.112-26.152) and low willingness among the missed individuals that felt physical discomfort after receiving the first dose (OR=0.168, 95%CI: 0.035-0.806). @*Conclusions@#The willingness to receive the second dose of the inactivated COVID-19 vaccine was low among the missed individuals, and high willingness is seen among the missed individuals with requirements of vaccination in the workplace and without physical discomfort after receiving the first dose of the inactivated COVID-19 vaccine.
RESUMO
Objective@#To investigate the awareness of knowledge about HPV infections and the willingness to HPV vaccination among male university students in Tongzhou District, Beijing Municipality, so as to provide insights into the formulation of the HPV vaccination strategy among males.@*Methods@#A total of 997 male university students in Tongzhou District were selected as the study subjects using a multi-stage stratified cluster random sampling method, and a self-designed questionnaire was used to investigate the awareness of HPV infections and HPV vaccine, and willingness to HPV vaccination. In addition, the factors affecting the willingness to HPV vaccination were identified. @*Results@#A total of 935 subjects were enrolled, with a mean age of (19.08±1.38) years, and there were 570 subjects with a Beijing household registration (60.96%). Among the 313 male university students that had heard of HPV, the awareness of HPV and HPV-related diseases was 59.42%, and among the 300 male university students that had heard of HPV vaccines, the awareness of HPV vaccines was 75.33%. The willingness to HPV vaccination was 38.50%, and the willingness was high among male university students with a non-Beijing household registration ( χ2=3.971, P=0.046 ), high household annual income ( χ2trend=6.219, P=0.013 ), short distance to vaccination clinics ( χ2=19.238, P<0.001 ), having heard of HPV ( χ2=11.188, P=0.001 ), having heard of HPV vaccine ( χ2=14.548, P<0.001 ), awareness of HPV and related diseases ( χ2=16.855, P<0.001 ) and awareness of HPV vaccine ( χ2=19.299, P<0.001 ).@*Conclusions@#The awareness of HPV and HPV vaccines and the willingness to HPV vaccination are low among male university students in Tongzhou District. Improving the correct recognition of HPV and HPV vaccines and the access to vaccination services are helpful to improve the willingness to HPV vaccination among male university students.
RESUMO
Objective To investigate measles antibody levels in healthy people in Jinshan District and their willingness to inoculate measles containing vaccines, and to explore the feasibility of supplementary immunization with adult measles vaccine. Methods People from 4 randomly selected community health service centers were enrolled and divided into groups of 15-19, 20-29, 30-39, and 40 years old and above. Serum was collected for measles antibody level detection and analysis according to the city and foreign household registration. In addition, a questionnaire survey on measles knowledge and vaccination willingness was conducted. Results Of the 234 participants for serum testing, the overall positive rate of measles antibodies (IgG) was 85.47%, and the protection rate was 35.47%. The difference in the positive rate of antibodies in different age groups was statistically significant (χ2=9.78, P=0.02), and the difference in the protection rate was also statistically significant (χ2=14.97, P<0.0012). The positive rate and protection rate were lowest in the group of 20-29 years old, which were 74.19% and 24.19%, respectively. A total of 490 questionnaires were sent out, and 477 questionnaires were effectively returned. Among the 5 questions about measles knowledge, the lowest correct rate was for the transmission route of measles, which was only 48.64%. The willingness to measles vaccination was 85.12%. Multivariate analysis showed that the willingness to vaccination was related to the level of awareness and health education. Conclusion The level of protective antibodies against measles was low in adults in Jinshan District. Health education on measles was insufficient. It is necessary to conduct measles health publicity in institutions with more concentrated personnel. In addition, appropriate measles serological monitoring and supplementary immunization should be carried out for key populations to increase the level of measles antibodies.